Monday, Oct 3, 2022
Science and Tech
Optimus interim phase 3 data for Molnupiravir shows 78.3% efficacy
The interim results on 353 patients showed that the drug has been successful in reducing viral load effectively with RT-PCR negativity.
Hetero’s phase 3 trial results of Molnupiravir shows fewer hospital admissions
Hyderabad-based pharma company has approached the Drug Controller General of India to seek Emergency Use Authorization for the investigational drug in India
Hyderabad: Clinical trials on for Covaxin for children
Several research activities are being carried out to study Variants of Concern and assess their suitability for follow-up booster doses, the company said here on Tuesday.
Plea in SC seeks disclosure of clinical trials data for COVID-19 vaccines
The plea filed through advocate Prashant Bhushan sought direction to the government to make public the segregated data of the clinical trials for the vaccines.
India to produce 850 million Sputnik doses annually: RDIF
India has become the 60th country to approve Sputnik V, RDIF, Russia's sovereign wealth fund, said in a statement.
The Whiteboard buys Cytel’s CLipLab
Making the announcement on Friday, The Whiteboard said that this acquisition increases its breadth of courses.
Zydus Cadila gets DCGI nod for Phase-3 clinical trials for Covid-19 vaccine
The Nation's first indigenously developed DNA vaccine candidate against COVID-19, ZyCoV-D, by M/s Zydus Cadila has been approved by Drugs Controller General of India (DCGI), for the conduct of the Phase III clinical trials
Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy
The trials, which will commence in December, will be conducted on 250 patients across 20-25 centres in India.
PM Modi reaches Ahmedabad to review coronavirus vaccine development
Zydus Cadila has announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D was over and it has commenced phase-II clinical trials from August.
Russia to produce Sputnik V Covid vaccine in India
According to the RDIF -- Russia's sovereign wealth fund, the vaccine's interim clinical trial results show 95 per cent efficacy on the 42nd day after the first dose.
IAF scrambles jets to intercept flight from Iran after bomb threat: Sources
6 mins ago
Hindu community protests in Balochistan after desecration of remains of Hindu woman’s body
16 mins ago
KTR meets Gangavva, says he’ll be guest on My Village Show soon
19 mins ago
Consuming refined grains may up risk of premature heart disease
36 mins ago
Lava launches its 1st 5G phone, to be priced around Rs 10k
45 mins ago
Millions of Indian smartphone users have to wait till 2024 for 5G
50 mins ago
Mahatma Gandhi look-alike Mahishasura idol in Kolkata creates controversy
1 hour ago
Bharat Jodo enters day 4 in Karnataka; Sonia, Priyanka likely to join Rahul Gandhi
1 hour ago